Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
SR One
Biotech
AirNexis swoops in with $200M series A for COPD asset
AirNexis has inked a deal potentially worth almost $1 billion with a China biopharma, securing rights to a clinical-stage COPD asset.
Gabrielle Masson
Jan 9, 2026 11:01am
Addition Tx does the math and emerges from stealth with $100M
Dec 17, 2025 7:45am
Zenas bags $200M series C to reach a handful of key mAB readouts
May 7, 2024 7:00am
CRISPR Tx director: It’s ‘still early days’ on sealing new deals
Jan 10, 2024 10:57am
Gary Glick's Odyssey begins with $218M for 7 assets
Dec 7, 2021 7:00am
HotSpot collects $100M to bankroll trials of allosteric drugs
Nov 29, 2021 7:00am
